You are managing a hybrid project for developing a medical device, where regulatory compliance work follows a waterfall approach with formal documentation and sign-offs, while the user interface development uses Kanban. The regulatory team has just completed validation protocols that must be signed by the quality assurance director before UI testing can begin. However, the QA director is unexpectedly on medical leave for two weeks, and the UI team has already completed their work and is ready to begin testing. The QA director's delegate can review documents but doesn't have signature authority. What is the best approach?

Question

Accepted Answer

The correct answer is A. This approach balances regulatory compliance requirements with adaptive flow optimization. Regulatory sign-offs cannot be bypassed (ruling out Option D), but the UI team can begin work on components with lower regulatory risk while completing the review process. Having the delegate prepare the recommendation ensures the QA director can sign promptly upon return. Option C is the main distractor because it treats all work as equal risk and creates unnecessary idle time, when hybrid approaches should optimize flow where possible within compliance constraints. Option B inappropriately escalates a temporary situation, and Option D violates regulatory compliance principles by implementing unauthorized testing.

PMP Practice Question: Process — Hybrid, Medium

More Process Questions